Lacey Richards, from Tycroes, survived a coma before becoming the first patient in Carmarthenshire to trial a new diabetes treatment ...

Building iteration into the product commercialization process can help life sciences companies avoid many of the missteps ...

Ex-Intel head says TSMC’s new investment will not resurrect US chip sector Read the Market Summary Here:- Global Blood Glucose Monitoring System Market is valued at approximately USD 16.46 billion in ...

A new clinical trial led by the Jaeb Center for Health Research has shown that automated insulin delivery (AID) systems can ...

Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...

Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, ...

CGMs are transforming health tracking for non-diabetics, providing insights into glucose levels and influencing dietary choices and athletic performance.

DexCom plans to launch its 15-day G7 sensor in the second half of 2025, pending FDA approval. A longer wear time may boost ...

The U.S. FDA’s March 4, 2025, warning letter to Dexcom Inc. is a well-detailed but heavily redacted document explaining the agency’s misgivings about procedures such as monitoring of acetaminophen ...

Jake Leach caught up with MedTech Dive during the ATTD conference to discuss new data on the company’s glucose monitors and ...

Amsterdam played host to this year's edition of the International Conference on Advanced Technologies & Treatments for ...

ATTD conference, experts debated whether patients who use continuous glucose monitoring should aim for normal glycemia.